Display Settings:

Format

Send to:

Choose Destination
    Mol Biol Rep. 2009 Jul;36(6):1257-61. Epub 2008 Jul 6.

    Complement factor H Y402H polymorphism, plasma concentration and risk of coronary artery disease.

    Source

    Clinical Medical College of Southeast University, Nanjing, 210009, People's Republic of China.

    Abstract

    BACKGROUND:

    Inflammation plays an important role in coronary artery disease (CAD). Complement Factor H (CFH) gene has been analyzed in relation to CAD in several studies with conflicting results. The aim of the present study was to investigate the association between the CFH Y402H polymorphism and CAD in Chinese.

    METHODS AND RESULTS:

    About 336 patients were enrolled, included 166 patients with CAD and 170 controls. The SNP at CFH Y402H was genotyped by ligase detection reaction and plasma levels of CFH were assayed by enzyme-linked immunosorbent assay. Analysis of genotype frequencies did not reveal any significant difference between CAD patients and controls. There were significant differences in the frequencies of C allele and C allele carriers between early-onset CAD and controls. After adjustment of clinical parameters, significant association was identified for CFH Y402H polymorphism, with C allele carriers having a higher risk of early-onset CAD than carriers of TT genotype (odds ratio [OR] 4.66, 95% CI: 1.23-17.62, P = 0.02). There was no difference of plasma CFH levels between CAD group and controls.

    CONCLUSIONS:

    CFH Y402H polymorphism is associated with early-onset CAD in Chinese.

    PMID:
    18604638
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk